Byline: Olivia Dimmer
-
Gene Therapies Could Transform Treatment of Rare Blood Disorders
A new gene therapy could revolutionize treatment for two rare genetic blood disorders, according to a pair of trials published in the New England Journal of Medicine.
-
Feinberg Faculty and Regulatory Affairs Welcomes New Senior Director
Joan Trimuel Williams has been named Feinberg’s senior director for Faculty and Regulatory Affairs.
-
Celebrating the MD Class of 2024
Feinberg honored the MD Class of 2024 during the medical school’s 165th commencement ceremony held in the Aon Grand Ballroom at Navy Pier on May 13.
-
How Herpes Hijacks a Ride into Cells
Northwestern Medicine scientists have discovered how herpes viruses hijack cellular transport processes to infiltrate the nervous system, according to a study published in the Proceedings of the National Academy of Sciences.
-
Weight Loss Drug Shows Benefits for Heart Failure
Semaglutide, sold under brand names Ozempic and Wegovy, can help reduce heart failure symptoms and reduce heart failure hospitalizations in patients with obesity, according to a pair of studies published in The Lancet and The New England Journal of Medicine.
-
B-Cells May Play Role in Lung Transplant Rejection
B-cells infiltrating the lungs may be responsible for one of the most common complications in lung transplantation that can lead to rejection, according to a study published in the Journal of Clinical Investigation.
-
Drug Shows Promise for Starving Out Cancer Cells
Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a study published in Science Advances.
-
Understanding Cellular Transcription Responses to Oxygen Deprivation
A multiprotein complex is essential for regulating cellular transcription response to oxygen deprivation, a key feature of cancer, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences.
-
Cancer Drug Trial Provides Lessons for Future
A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
-
Feinberg Investigators Lead AHA Heart Disease Research Initiative
Feinberg investigators have been selected to lead a $15 million American Heart Association research initiative studying the role of inflammation in heart disease.
